General Information
DRACP ID DRACP01995
Peptide Name
Sequence GFWARIGKVFAAVKNL
Sequence Length 16
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP Membrane-targeted
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
MCF-7 | Invasive breast carcinoma of no special type | Carcinoma | EC50=101±4 µM | Not available | Not available | 1 |
Hemolytic Activity Human erythrocytes: Not active up to 400 µM
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C86H133N23O18
Absent amino acids CDEHMPQSTY
Common amino acids A
Mass 204489
Pl 11.82
Basic residues 3
Acidic residues 0
Hydrophobic residues 10
Net charge 3
Boman Index 86
Hydrophobicity 63.75
Aliphatic Index 103.75
Half Life
Mammalian: 1.3 hour
Yeast: 3 min
E.coli: 2 min
Extinction Coefficient cystines 5500
Absorbance 280nm 366.67
Polar residues 3
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 29679519
Title Designing Anticancer Peptides by Constructive Machine Learning
Year 2018
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID DBAASPS_14297